ABL Diagnostics S.A. (ABLD)
Euronext
Closed
Oct 8, 2026
Day's Range
2.1052 wk Range
2.10Overview - ABLD - ABL Diagnostics S.A.
Key Statistics
Valuation
Enterprise Value
36.84M
P/E (Trailing)
‪18.16‬
P/E (Forward)
‪37.00‬
Price / Sales (TTM)
‪3.32‬
Price / Book
‪4.58‬
EV / EBITDA
‪36.04‬
Profitability
Gross Margin
‪61.03%‬
Profit Margin
‪18.77%‬
Operating Margin
‪20.59%‬
Return on Assets
‪7.61%‬
Return on Equity
‪12.92%‬
Ownership
Shares Outstanding
16.06M
Float
990.03K
Held by Insiders
‪93.57%‬
Held by Institutions
‪0.00%‬
Price stats
Beta
‪-0.52‬
50-Day Avg
‪2.41‬
200-Day Avg
‪2.89‬
Dividends
Payout Ratio
‪89.43%‬
Frequency
Annual
Analyst Consensus
1 analysts
Market Cap - ABLD - ABL Diagnostics S.A.
Peers - ABLD - ABL Diagnostics S.A.
Peer Comparison
Compared with companies in Health Information Services listed on Euronext.
- ABLDEuronextABL Diagnostics S.A.35.67MMarket Cap-102.70%52-week change18.17P/E (Trailing)‪18.77%‬Profit Margin
- CAPEuronextCapgemini SE18.07BMarket Cap-14.42%52-week change13.84P/E (Trailing)‪5.86%‬Profit Margin
- EQSEuronextEquasens Société anonyme437.43MMarket Cap-55.84%52-week change11.62P/E (Trailing)‪16.62%‬Profit Margin
- CGMEuronextCegedim S.A.153.28MMarket Cap+3.46%52-week change92.86P/E (Trailing)‪-2.24%‬Profit Margin
- PHREuronextPharol, SGPS S.A.73.38MMarket Cap+27.66%52-week change2.30P/E (Trailing)‪0.00%‬Profit Margin
- ALALSMAEuronextSmaio S.A.43.81MMarket Cap+6.60%52-week change16.30P/E (Trailing)‪-24.32%‬Profit Margin
- ALINSEuronextIntrasense S.A.10.26MMarket Cap-45.13%52-week change—P/E (Trailing)‪-244.82%‬Profit Margin
Profile Summary - ABLD - ABL Diagnostics S.A.
About
ABL Diagnostics S.A. is a biotechnology company specializing in innovative molecular biology tests and comprehensive solutions for microbiology diagnostics. It develops and markets proprietary assays including DeepChek® for genotyping through DNA sequencing and UltraGene® for molecular polymerase chain reaction (PCR)…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
